Fill-finish Pharmaceutical Contract Manufacturing Market To Reach $29.06 Billion By 2030

Fill-Finish Pharmaceutical Contract Manufacturing Market Growth & Trends

The global fill-finish pharmaceutical contract manufacturing market size is estimated to reach USD 29.06 billion by 2030, expanding at a CAGR of 8.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for injectable drugs is one of the primary drivers of the fill-finish pharmaceutical contract manufacturing market. Injectable drugs are medications that are delivered directly into the bloodstream, muscle tissue, or other parts of the body using a needle and syringe or other delivery system. These drugs are used to treat a wide range of conditions, including cancer, autoimmune disorders, and infectious diseases, among others.

The demand for injectable drugs has been growing steadily in recent years due to several factors. One of the key drivers is the increasing prevalence of chronic diseases such as cancer and diabetes, which require long-term treatment with injectable medications. Additionally, the development of new biologic drugs, which are often administered via injection, has also contributed to the growing demand for injectable drugs.

The COVID-19 pandemic has had a significant impact on the market. Fill-finish contract manufacturing is an essential part of the pharmaceutical industry, which involves the filling and finishing of drug products into vials, syringes, cartridges, and other delivery systems. The pandemic caused disruptions in the global supply chain, resulting in shortages of raw materials and other critical components required for operations. This has led to delays in the production of drugs and vaccines, particularly those used in the treatment of COVID-19 patients.

Moreover, the pandemic has also caused an increase in demand for certain drugs and vaccines, further straining the capacity of fill-finish contract manufacturers. Many manufacturers have been forced to operate at reduced capacity due to social distancing guidelines and other restrictions imposed to control the spread of the virus.

 Request a free sample copy or view report summary: Fill-Finish Pharmaceutical Contract Manufacturing Market Report

Fill-Finish pharmaceutical Contract Manufacturing Market Report Highlights

• The large molecules segment accounted for the largest revenue share of 67.3% in 2024 due to the rising potential to treat unmet medical needs.

• The vials segment is accounted for the highest revenue share of 53.4% in 2024 due to increasing technological advancements in vial filling equipment.

• The biopharmaceutical companies segment accounted for the highest revenue share of 55.3% in 2024, an increase in the development of drugs and vaccines is the key factor for the growth of the market.

• By region, North America fill-finish pharmaceutical contract manufacturing market dominated the global market with a revenue share of 34.9% in 2024.

Fill-Finish Pharmaceutical Contract Manufacturing Market Segmentation

Grand View Research has segmented the global fill-finish pharmaceutical contract manufacturing market based on product, molecule, end use, and region:

Fill-finish Pharmaceutical Contract Manufacturing Product Outlook (Revenue, USD Million, 2018 - 2030)

• Prefilled Syringes

• Vials

• Cartridges

• Others

Fill-finish Pharmaceutical Contract Manufacturing Molecule Outlook (Revenue, USD Million, 2018 - 2030)

• Large Molecules

• Small Molecules

Fill-finish Pharmaceutical Contract Manufacturing End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Biopharmaceutical Companies

• Pharmaceutical Companies

Fill-finish Pharmaceutical Contract Manufacturing Regional Outlook (Volume, Kilotons; Revenue, USD Billion, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Fill-Finish Pharmaceutical Contract Manufacturing Market

• Thermo Fisher Scientific Inc.

• Sartorius AG

• Boehringer Ingelheim International GmbH

• Catalent, Inc (acquired by Novo Holdings A/S)

• Societal CDMO (Recro Pharma, Inc)

• Baxter

• Eurofins Scientific

• Symbiosis Pharmaceutical Services Ltd

• MabPlex International Co. Ltd.

• Recipharm AB

• Fresenius Kabi, USA LLC

• Lonza